Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $25
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.
Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.